Quick Answer
ORAMED PHARMACEUTICALS INC. reported Shares Outstanding of 39.28 million shares for fiscal year 2025.
ORAMED PHARMACEUTICALS INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 39.28M | -1.6% |
| 2024 | 39.92M | -1.0% |
| 2023 | 40.34M | +2.0% |
| 2022 | 39.56M | +3.7% |
| 2021 | 38.16M | +8.1% |
| 2021 | 35.29M | +49.1% |
| 2020 | 23.68M | +36.2% |
| 2019 | 17.38M | +0.1% |
| 2018 | 17.37M | +27.1% |
| 2017 | 13.67M | +3.7% |
| 2016 | 13.18M | +14.0% |
| 2015 | 11.56M | +14.5% |
| 2014 | 10.10M | +27.3% |
| 2013 | 7.94M | +10.2% |
| 2013 | 7.20M | +7.9% |
| 2012 | 6.67M | -90.5% |
| 2011 | 70.10M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 40.84M | +1.6% | -0.0% |
| June 30, 2025 | 40.85M | +0.5% | -0.0% |
| March 31, 2025 | 40.85M | +0.8% | +2.3% |
| December 31, 2024 | 39.92M | -1.0% | -0.7% |
| September 30, 2024 | 40.21M | -0.2% | -1.0% |
| June 30, 2024 | 40.63M | +1.0% | +0.3% |
| March 31, 2024 | 40.52M | +1.4% | +0.4% |
| December 31, 2023 | 40.34M | +2.0% | +0.1% |
- ORAMED PHARMACEUTICALS INC. showed a decrease of -1.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, ORAMED PHARMACEUTICALS INC.’s shares outstanding has declined by 44.0% (from 70.10 million shares to 39.28 million shares).
- The most recent figure is from ORAMED PHARMACEUTICALS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: